Recent News

• 09.17.2025 - Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
• 09.17.2025 - Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
• 09.04.2025 - SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 08.27.2025 - Invivyd to Participate in Upcoming Investor Conferences
• 08.27.2025 - Invivyd to Participate in Upcoming Investor Conferences

Recent Filings

• 09.08.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.27.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.26.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.22.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.22.2025 - EX-99.1 EX-99.1
• 08.22.2025 - 8-K Current report